It's too late anyway: the company already filed for Food and Drug Administration approval of CagriSema, with a decision expected in late 2026
Running, especially long-distance running, requires a higher calorie intake to maintain energy levels
Today, PT-141 is FDA-approved for premenopausal women with hypoactive sexual desire disorder (HSDD), a condition marked by a persistent lack of sexual desire that causes distress or strain in relationships
GIP is excessively secreted after nutrient consumption, and it promotes fat deposition in adipose tissue (27)
Statistical analysis Descriptive statistics were used to summarize demographics, therapy characteristics, and weight outcomes across therapy duration groups
After 36 weeks of open-label tirzepatide, participants either continued or switched to placebo